Skip to content

Rohan Borschmann

3 papers in the library · 101 citations · publishing 2013-2016

Papers

Sort Most recent Most cited

Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample.

Drug and Alcohol Review March 1, 2016 Adam Winstock, Will Lawn, P. Deluca et al.

AbstractIntroduction and AimsTo assess the prevalence of use and subjective effect profile of methoxetamine among a group of polydrug users.Design and MethodsCross‐sectional, anonymous, online survey of UK‐based polydrug users was conducted. Prevalence of lifetime, last year and last month use, sourcing of the drugs, motivations for use, and subjective effect and risk profile compared with that...

Methoxetamine: prevalence of use in the USA and UK and associated urinary problems

October 7, 2014 Will Lawn, Rohan Borschmann, A. Cottrell et al.

Background: Methoxetamine is a novel psychoactive substance and a legal alternative to ketamine in many countries, including parts of the United States. Frequent recreational ketamine use can cause lower urinary tract symptoms, whereas methoxetamine was originally marketed as “bladder friendly”.Aims: (1) To determine changes in prevalence of methoxetamine use between 2011 and 2012 in the USA...

Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample

Journal of Psychopharmacology November 27, 2013 Adam Winstock, Stephen J. Kaar, Rohan Borschmann 101 citations

This paper presents original research on prevalence, user characteristics and effect profile of N,N-dimethyltryptamine (DMT), a potent hallucinogenic which acts primarily through the serotonergic system. Data were obtained from the Global Drug Survey (an anonymous online survey of people, many of whom have used drugs) conducted between November and December 2012 with 22,289 responses. Lifetime...